Concord Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.8K | Sell |
575
-591
| -51% | -$65.5K | 0.01% | 315 |
|
|
2025
Q1 | $131K | Sell |
1,166
-8,209
| -88% | -$920K | 0.02% | 221 |
|
|
2024
Q4 | $866K | Buy |
9,375
+6,194
| +195% | +$572K | 0.14% | 112 |
|
|
2024
Q3 | $267K | Sell |
3,181
-202
| -6% | -$16.9K | 0.04% | 183 |
|
|
2024
Q2 | $232K | Sell |
3,383
-16,533
| -83% | -$1.13M | 0.04% | 183 |
|
|
2024
Q1 | $1.46M | Buy |
19,916
+1,561
| +9% | +$114K | 0.26% | 78 |
|
|
2023
Q4 | $1.49M | Buy |
18,355
+4,684
| +34% | +$379K | 0.3% | 72 |
|
|
2023
Q3 | $1.02M | Buy |
13,671
+4,376
| +47% | +$328K | 0.22% | 78 |
|
|
2023
Q2 | $716K | Buy |
9,295
+4,290
| +86% | +$331K | 0.15% | 88 |
|
|
2023
Q1 | $415K | Buy |
5,005
+4,615
| +1,183% | +$383K | 0.12% | 94 |
|
|
2022
Q4 | $33.5K | Buy |
+390
| New | +$33.5K | 0.01% | 448 |
|
|
2022
Q3 | – | Sell |
-694
| Closed | -$43K | – | 533 |
|
|
2022
Q2 | $43K | Sell |
694
-1,603
| -70% | -$99.3K | 0.01% | 398 |
|
|
2022
Q1 | $137K | Buy |
2,297
+152
| +7% | +$9.07K | 0.04% | 241 |
|
|
2021
Q4 | $156K | Buy |
2,145
+1,901
| +779% | +$138K | 0.04% | 223 |
|
|
2021
Q3 | $17K | Sell |
244
-1,225
| -83% | -$85.3K | 0.01% | 402 |
|
|
2021
Q2 | $101K | Buy |
1,469
+424
| +41% | +$29.2K | 0.03% | 235 |
|
|
2021
Q1 | $68K | Buy |
1,045
+1,027
| +5,706% | +$66.8K | 0.02% | 280 |
|
|
2020
Q4 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 622 |
|